DISCOUNT-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000HC8QCM8

Real-time BOERSE MUENCHEN 03:16:22 04/06/2024 pm IST
3.96 EUR -0.75% Intraday chart for DISCOUNT-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month-0.75%
1 month+2.31%
Date Price Change
04/24/04 3.96 -0.75%
03/24/03 3.99 -0.75%
31/24/31 4.02 -0.50%
30/24/30 4.04 -0.74%
29/24/29 4.07 +2.01%

Real-time BOERSE MUENCHEN

Last update June 04, 2024 at 03:16 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer UniCredit UniCredit
WKN HC8QCM
ISINDE000HC8QCM8
Date issued 15/08/2023
Strike 50
Maturity 18/12/2024 (198 Days)
Parity 1 : 1
Emission price 2.54
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.5
Lowest since issue 2.45
Spread 0.03
Spread %0.75%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.25 EUR
Average target price
39.97 EUR
Spread / Average Target
+1.84%
Consensus